CYCLIN D1 AND RETINOBLASTOMA GENE EXPRESSION IN HUMAN BREAST CARCINOMA: CORRELATION WITH TUMOUR PROLIFERATION AND OESTROGEN RECEPTOR STATUS
暂无分享,去创建一个
E. Campo | P. Jares | A. Nadal | M. Muñoz | A. Cardesa | J. Muntané | C. Mallofré | M. Rey | J. Estapé | P. Fernández | I. Nayach
[1] B. Jennings,et al. Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression , 1996, Clinical molecular pathology.
[2] B. Angus,et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. , 1995, Oncogene.
[3] E. Schmidt,et al. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[4] J. Foekens,et al. Association between rb‐1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survival , 1995, International journal of cancer.
[5] J. Bartek,et al. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. , 1995, Cancer letters.
[6] J. Bartek,et al. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. , 1995, Oncogene.
[7] V. Kosma,et al. Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. , 1995, European journal of cancer.
[8] Jun-yan Hong,et al. Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric‐cardia carcinogenesis , 1994, International journal of cancer.
[9] A. Klein-Szanto,et al. Immunohistochemistry of cyclin D1 in human breast cancer. , 1994, American journal of clinical pathology.
[10] R. Chaganti,et al. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines , 1994, International journal of cancer.
[11] A. López-Guillermo,et al. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma , 1994 .
[12] F. Bosch,et al. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. , 1994, Cancer research.
[13] R. Sclafani,et al. Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[14] W. Benedict,et al. Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti‐RB antibodies , 1994, International journal of cancer.
[15] A. El‐Naggar,et al. PRAD‐1 (CCND1)/Cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma , 1994, Cancer.
[16] Emma Lees,et al. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice , 1994, Nature.
[17] L. Bonetta,et al. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. , 1994, Oncogene.
[18] Jiri Bartek,et al. Cyclin D1 protein expression and function in human breast cancer , 1994, International journal of cancer.
[19] J. Bartek,et al. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1 , 1994, The Journal of cell biology.
[20] J. Bartek,et al. Cyclin D1 expression is regulated by the retinoblastoma protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Bartek,et al. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. , 1994, Cancer research.
[22] J. Bartek,et al. Cell cycle‐related variation and tissue‐restricted expression of human cyclin D1 protein , 1994, The Journal of pathology.
[23] R. Weinberg,et al. Function of a human cyclin gene as an oncogene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[24] N. Sonenberg,et al. Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E , 1993, Molecular and cellular biology.
[25] R. Sutherland,et al. Cyclin gene expression and growth control in normal and neoplastic human breast epithelium , 1993, The Journal of Steroid Biochemistry and Molecular Biology.
[26] H. Sakamoto,et al. Amplification and overexpression of EXP1 and EXP2/Cyclin D1 genes in human esophageal carcinomas. , 1993, Biochemical and biophysical research communications.
[27] C. J. Chen,et al. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. , 1993, Biochemical and biophysical research communications.
[28] C. Harris,et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. A. Hamilton,et al. Expression and amplification of cyclin genes in human breast cancer. , 1993, Oncogene.
[30] S. Shurtleff,et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. , 1993, Genes & development.
[31] J. A. Hamilton,et al. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. , 1993, Molecular and cellular biology.
[32] R. Weinberg,et al. Physical interaction of the retinoblastoma protein with human D cyclins , 1993, Cell.
[33] M. Ewen,et al. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. , 1993, Genes & development.
[34] K. Keyomarsi,et al. Redundant cyclin overexpression and gene amplification in breast cancer cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[35] W. Cavenee,et al. Retinoblastoma and p53 gene product expression in breast carcinoma: immunohistochemical analysis and clinicopathologic correlation. , 1992, Human pathology.
[36] M. J. van de Vijver,et al. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. , 1992, Cancer research.
[37] B. Angus,et al. Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: An immunohistochemical study , 1992, The Journal of pathology.
[38] N. Harris,et al. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[39] O. Melnyk,et al. Characterization of a candidate bcl-1 gene , 1991, Molecular and cellular biology.
[40] B. Futcher,et al. Human D-type cyclin , 1991, Cell.
[41] A. Arnold,et al. A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.
[42] M. Fernö,et al. Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. , 1991, British Journal of Cancer.
[43] R. Figlin,et al. Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group. , 1990, Oncogene.
[44] G. Peters,et al. Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. , 1990, European journal of cancer.
[45] I. Ellis,et al. Pathology and breast screening , 1990, Histopathology.
[46] D. Birnbaum,et al. BCL-1 participates in the 11q13 amplification found in breast cancer. , 1990, Oncogene.
[47] Y. Fujiwara,et al. Mechanisms of estrogen action on the proliferation of MCF-7 human breast cancer cells in an improved culture medium. , 1989, Cancer research.
[48] C. Theillet,et al. Proto-oncogene amplification and human breast tumor phenotype. , 1989, Oncogene.
[49] R. Eddy,et al. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. , 1989, The Journal of clinical investigation.
[50] S. Hirohashi,et al. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. , 1989, Cancer research.
[51] G. Merlo,et al. The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci. , 1989, Oncogene.
[52] R. Clarke,et al. Regulation of breast cancer cells by hormones and growth factors: effects on proliferation and basement membrane invasiveness. , 1989, Hormone research.
[53] J. Varley,et al. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. , 1988, Science.
[54] W. Lee,et al. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. , 1988, Science.
[55] B. Leung,et al. Mode of estrogen action on cell proliferation in CAMA‐1 cells: II. Sensitivity of G1 phase population , 1987, Journal of cellular biochemistry.
[56] E B Cox,et al. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. , 1985, Archives of pathology & laboratory medicine.
[57] I W Taylor,et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. , 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[58] M. Lippman,et al. Oestrogen-responsive human breast cancer in long term tissue culture , 1975, Nature.